89 related articles for article (PubMed ID: 9699652)
1. Human breast cancer cells contain an error-prone DNA replication apparatus.
Sekowski JW; Malkas LH; Schnaper L; Bechtel PE; Long BJ; Hickey RJ
Cancer Res; 1998 Aug; 58(15):3259-63. PubMed ID: 9699652
[TBL] [Abstract][Full Text] [Related]
2. The human breast cell DNA synthesome: its purification from tumor tissue and cell culture.
Coll JM; Sekowski JW; Hickey RJ; Schnaper L; Yue W; Brodie AM; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1996; 8(10-11):435-47. PubMed ID: 9114436
[TBL] [Abstract][Full Text] [Related]
3. A unique form of proliferating cell nuclear antigen is present in malignant breast cells.
Bechtel PE; Hickey RJ; Schnaper L; Sekowski JW; Long BJ; Freund R; Liu N; Rodriguez-Valenzuela C; Malkas LH
Cancer Res; 1998 Aug; 58(15):3264-9. PubMed ID: 9699653
[TBL] [Abstract][Full Text] [Related]
4. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a DNA synthesome from a neuroblastoma cell line.
Sandoval JA; Hickey RJ; Malkas LH
J Pediatr Surg; 2005 Jul; 40(7):1070-7. PubMed ID: 16034747
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the human neuroblastoma DNA replication complex: insights into faulty proliferation.
Sandoval JA; Grosfeld JL; Hickey RJ; Malkas LH
J Pediatr Surg; 2006 Jan; 41(1):266-70. PubMed ID: 16410145
[TBL] [Abstract][Full Text] [Related]
7. Mercuric ion inhibits the activity and fidelity of the human cell DNA synthesome.
Sekowski JW; Malkas LH; Wei Y; Hickey RJ
Toxicol Appl Pharmacol; 1997 Aug; 145(2):268-76. PubMed ID: 9266799
[TBL] [Abstract][Full Text] [Related]
8. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of the human cell multiprotein DNA replication complex.
Applegren N; Hickey RJ; Kleinschmidt AM; Zhou Q; Coll J; Wills P; Swaby R; Wei Y; Quan JY; Lee MY
J Cell Biochem; 1995 Sep; 59(1):91-107. PubMed ID: 8530540
[TBL] [Abstract][Full Text] [Related]
10. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
11. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
Abdel-Aziz W; Hickey RJ; Malkas LH
Biochem Pharmacol; 2004 Jul; 68(1):11-21. PubMed ID: 15183113
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
14. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
15. Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome.
Dai H; Liu J; Malkas LH; Catalano J; Alagharu S; Hickey RJ
Toxicol Appl Pharmacol; 2009 Apr; 236(2):154-65. PubMed ID: 19371627
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
17. Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.
Coll JM; Hickey RJ; Cronkey EA; Jiang HY; Schnaper L; Lee MY; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1997; 9(11-12):629-39. PubMed ID: 9563011
[TBL] [Abstract][Full Text] [Related]
18. Human cell DNA replication is mediated by a discrete multiprotein complex.
Jiang HY; Hickey RJ; Abdel-Aziz W; Tom TD; Wills PW; Liu J; Malkas LH
J Cell Biochem; 2002; 85(4):762-74. PubMed ID: 11968016
[TBL] [Abstract][Full Text] [Related]
19. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
Gonzalez MA; Tachibana KE; Chin SF; Callagy G; Madine MA; Vowler SL; Pinder SE; Laskey RA; Coleman N
J Pathol; 2004 Oct; 204(2):121-30. PubMed ID: 15376260
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
